Role of the GABA transporter, GAT-3, in regulating network excitability in the hippocampus
Role of the GABA transporter, GAT-3, in regulating network excitability in the hippocampus
批准号:
MR/P025641/1
负责人:
Matthew Walker
金额:
$60.73万
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2017
资助国家:
英国
项目状态:
已结题
起止时间:
2017 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The hippocampus is a part of the brain that plays a key role in memory and learning. Damage to or dysfunction of the hippocampus is important for the symptoms of a number neurological diseases including Alzheimer's disease and epilepsy. Indeed, damage to the hippocampus from prolonged convulsions in childhood is the commonest cause of drug-resistant epilepsy.In order for the hippocampus to operate normally, there is a fine balance between excitation mediated by the neurotransmitter glutamate, and inhibition mediated by the neurotransmitter GABA. Understanding how these two processes work can help understand the manifestations of neurological disease and how to treat them.Throughout the brain there are nerve cells and glia. Nerve cells communicate with one another and are crucial for brain activity. Glia were once considered "the glue" of the brain and to play purely a supportive role. However, one of the major recent advances in neuroscience is the realisation that glia also play a critical role in brain activity and can also "communicate" to one another and to neurons.Glia can regulate GABA in the hippocampus by mean of a GABA transporter termed GAT3, but also we have recently discovered that activation of GAT3 can result in the release of other chemicals that modify hippocampal function. This research asks how do these different roles of GAT3 complement one another and how does GAT3 control inhibition in the hippocampus. In addition, we will be asking whether modifying GAT3 activity can be used to treat epilepsy.Addressing these questions is critical as GAT3 is a druggable target that could be used to treat a range of neurological and neurodegenerative conditions from epilepsy to Alzheimer's disease.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1111/epi.13965
发表时间:
2018-01
期刊:
Epilepsia
影响因子:
5.6
作者:
[Klein P, Dingledine R, Aronica E, Bernard C, Blümcke I, Boison D, Brodie MJ, Brooks-Kayal AR, Engel J Jr, Forcelli PA, Hirsch LJ, Kaminski RM, Klitgaard H, Kobow K, Lowenstein DH, Pearl PL, Pitkänen A, Puhakka N, Rogawski MA, Schmidt D, Sillanpää M, Sloviter RS, Steinhäuser C, Vezzani A, Walker MC, Löscher W]
通讯作者:
Löscher W
Replacing valproate with a safer, broad-spectrum drug for epilepsy treatment
-
批准号:MR/Y019334/1
-
项目类别:Research Grant
-
资助金额:$348.51万
-
财政年份:2024
-
负责人:Matthew Walker
-
依托单位:
Collaborative Research: Dwarf Galaxies Over Cosmic Time
-
批准号:2206046
-
项目类别:Standard Grant
-
资助金额:$35.7万
-
财政年份:2022
-
负责人:Matthew Walker
-
依托单位:
Collaborative Research: Finding the Double Sunsets - Stellar Multiplicity Across the Milky Way Halo
-
批准号:1909584
-
项目类别:Standard Grant
-
资助金额:$54.9万
-
财政年份:2019
-
负责人:Matthew Walker
-
依托单位:
Collaborative Research: Dark Matter and Substructure in the Galactic Halo with Gaia and Multi-Object Spectroscopy
-
批准号:1813881
-
项目类别:Standard Grant
-
资助金额:$58.6万
-
财政年份:2018
-
负责人:Matthew Walker
-
依托单位:
Collaborative Research: Do We Need Something Beyond Cold Dark Matter?
-
批准号:1412999
-
项目类别:Standard Grant
-
资助金额:$26.4万
-
财政年份:2014
-
负责人:Matthew Walker
-
依托单位:
Collaborative Research: Dwarf Galaxies and the Nature of Dark Matter
-
批准号:1313045
-
项目类别:Continuing Grant
-
资助金额:$12.93万
-
财政年份:2013
-
负责人:Matthew Walker
-
依托单位:
Neurocognitive Dynamics Of Sleep Onset
-
批准号:0121953
-
项目类别:Standard Grant
-
资助金额:$5.92万
-
财政年份:2001
-
负责人:Matthew Walker
-
依托单位:
Neurocognitive Dynamics Of Sleep Onset
-
批准号:0296214
-
项目类别:Standard Grant
-
资助金额:$0.0万
-
财政年份:2001
-
负责人:Matthew Walker
-
依托单位:
国内基金
海外基金
登录
查看更多内容
脑胶质母细胞瘤中SLC1A3⁺小胶质细胞通过Glu-GABA代谢失衡诱导T细胞耗竭的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:崔舒
-
依托单位:
基于GABA能神经环路探讨乌藤疏肝丸重塑神经兴奋-抑制平衡的抗抑郁机制
-
批准号:2026JJ30174
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘晓亭
-
依托单位:
从肝失疏泄探讨肝脏代谢物介导IL-6/STAT3通路调控GABA能系统对睡眠节律影响的机制及逍遥散的干预作用
-
批准号:2026JJ30175
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:滕永杰
-
依托单位:
背根神经节GABA重摄取改变在神经痛中的作用及其机制研究
-
批准号:JCZRLH202600149
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
糖基化α-Dystroglycan重塑GABA能突触连接在慢性应激所致认知损伤中的作用及机制研究
-
批准号:JCZRQN202500537
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
肠道谷氨酸代谢异常与额顶网络
Glu/GABA失衡介导抑郁症认知损害的肠-
脑关联研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:黄园园
-
依托单位:
加速iTBS(aiTBS)调控的Glu/GABA能神经E/I平衡对快感缺失型抑郁症的作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:黎兴兴
-
依托单位:
γ-氨基丁酸(GABA)发酵生产关键技术成果转化项目
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
热水与GABA处理对血橙采后品质与代谢的影响
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:马晓丽
-
依托单位:
原儿茶醛靶向GABA-A受体抑制巨噬细胞GSDMD/STING通路改善脓毒症心肌病的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:刘晓华
-
依托单位: